scholarly journals Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti-hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes

2018 ◽  
Vol 36 (4) ◽  
pp. 491-498 ◽  
Author(s):  
O. Montvida ◽  
J. B. Green ◽  
J. Atherton ◽  
S. K. Paul
Keyword(s):  
Type 2 Diabetes ◽  
Real World ◽  
Pancreatic Diseases ◽  
Real World Evidence

Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes

Diabetes Care ◽  
2017 ◽  
Vol 41 (1) ◽  
pp. 69-78 ◽  
Author(s):  
Olga Montvida ◽  
Jonathan Shaw ◽  
John J. Atherton ◽  
Frances Stringer ◽  
Sanjoy K. Paul
Keyword(s):  
Type 2 Diabetes ◽  
Real World ◽  
Newly Diagnosed ◽  
Drug Usage ◽  
Real World Evidence ◽  
Long Term Trends ◽  
The U.S

scholarly journals Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives

2020 ◽  
Vol 11 (S2) ◽  
pp. 33-48 ◽  
Author(s):  
Kamlesh Khunti ◽  
Mohamed Hassanein ◽  
Moon-Kyu Lee ◽  
Viswanathan Mohan ◽  
Aslam Amod
Keyword(s):  
Type 2 Diabetes ◽  
Real World ◽  
Real World Evidence

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes)

2017 ◽  
Vol 27 (12) ◽  
pp. 1089-1097 ◽  
Author(s):  
G.P. Fadini ◽  
G. Zatti ◽  
A. Consoli ◽  
E. Bonora ◽  
G. Sesti ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Real World ◽  
Real World Evidence
Sign in / Sign up

Export Citation Format

Share Document